A Phase II, Randomized, Controlled, Open-Label Trial of Combination Therapy With Nelfinavir (NFV) and Saquinavir (SQV)Sgc With Delavirdine (DLV) or 3TC/ZDV Versus Nelfinavir (NFV) and 3TC/ZDV in Subjects With HIV Infection and > 5,000 HIV RNA Copies/ML
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Delavirdine; Lamivudine/zidovudine; Nelfinavir; Saquinavir
- Indications HIV infections
- Focus Therapeutic Use
Most Recent Events
- 09 Mar 2015 Biomarkers information updated
- 07 Mar 2011 New trial record